With the growth of the cell-gene therapy (CGT) market, the contract development and manufacturing organization (CDMO) business targeting such treatments is also growing.However, industry executives express concern about a “mismatch” between domestic CDMOs and CGT developers.Last Wednesday, Ahn Jong-
GC said it has signed a joint research and development agreement with Immetas Therapeutics, a U.S.-based pharmaceutical firm, related to mRNA therapeutics for autoimmune diseases.Through this joint research, both companies will develop autoimmune disease therapeutics using Immetas' unique platform f
Bayer Korea said it has appointed Lee Jin-a, the current CEO of Bayer Thailand, as its new CEO of Bayer Group in Korea in charge of its pharmaceutical, consumer health, and crop science divisions, effective from Nov. 1.Lee will become the first Korean CEO in Bayer Group’s Korean offshoot history.Acc
Bayer's kidney drug Kerendia (finerenone) has been recognized as adequate for receiving insurance benefits by the Pharmaceutical Reimbursement Evaluation Committee.Kolon Pharma's three-drug inhaler Trimbow (beclometasone/formoterol/glycopyrronium) and Takeda's hemophilia drug Obizur (susoctocog alph
Hanall Biopharma and Daewoong Pharmaceutical have entered clinical trials for their new pipeline, targeting the 10 trillion won ($7.46 billion) global Parkinson's disease treatment market.Hanall, Daewoong, and NurrOn Pharmaceuticals said Thursday that they have completed the first dosing of patients
MSD Korea's application for a bulk reimbursement expansion for 13 indications of Keytruda (pembrolizumab) has been rejected at the first threshold.On Wednesday, the Health Insurance Review and Assessment Service (HIRA) released the results of its deliberations on the reimbursement standards for drug
As SK chemicals moves forward with the sale of its pharmaceutical division, labor unions have declared their opposition to the sale.The union has made clear its opposition to the sale, saying that workers will have to bear the brunt of the restructuring and damages caused by the planned sale.SK chem
DuchemBio announced on Thursday that it has obtained a license from the Korea Institute of Nuclear Safety (KINS) for a recovery and refining facility to recycle oxygen-18 (O-18) concentrate, successfully achieving the localization of a key material for radiopharmaceuticals that were previously entir
Samjin Pharmaceutical and AriBio are accelerating clinical trial preparations to develop a homegrown dementia treatment.Samjin and AriBio said Wednesday that they completed an expert meeting, "POLARIS AD AR1001 Global PⅢ Trial Meeting," last Friday and Saturday ahead of the domestic phase 3 clinical
CanariaBio, a Korean biotech company listed on Kosdaq, said it has entered into an exclusive distribution and license agreement with Hikma MENA FZE for the commercialization of oregovomab, an immunotherapy for ovarian cancer, in the Middle East and North Africa (MENA) region.Hikma MENA FTZ, which wi
A series of recent drug mispackaging incidents have put the manufacturing process management of domestic pharmaceutical companies under scrutiny.This time, the mix-up incident involved a dyslipidemia drug produced by Daewon Pharmaceutical. The incident's aftermath will be closely watched as Daewon p
Baxter Korea on Tuesday announced the release of Olimel N12E, a protein-rich Total Parenteral Nutrition (TPN) fluid for critically ill patients, with health insurance coverage beginning on Oct. 1.Olimel N12E contains 76 grams of amino acids and 950 calories per 1,000 mL, marking an approximately 33
SK plasma said that it has signed a term sheet with the Indonesia Investment Authority (INA) for the establishment of its blood products plant in Indonesia.The company's spokesperson did not reveal the exact location of the plant but said it would be near Jakarta. INA was established in Nov. 2020 an
Hanmi Pharm said Tuesday it participated in a symposium organized by Congenital Hyperinsulinism International (CHI) in The Hague, Netherlands, from Sept. 22-24 to introduce its LAPS GLP-2 analog, HM15912, under development to treat the disease.CHI is a non-profit organization founded in 2005 to impr
As the opening of the European Society for Medical Oncology Annual Meeting (ESMO 2023), Europe's largest cancer conference, draws near, attention here is focused on Korean participants.Along with the American Society of Clinical Oncology (ASCO) and the American Association of Cancer Research (AACR),
Eight out of 10 patients administered the ultra-expensive drug, Kymriah Inj., which costs hundreds of millions of won, did not achieve meaningful therapeutic results, a lawmaker pointed out.The legislator emphasized the need to increase the reimbursement rate for pharmaceutical companies if these ex
GC Cell said on Friday that it signed an agreement with IQVIA, the world's largest contract research organization (CRO), to conduct a multicountry phase 1 clinical trial of its CAR-NK cell therapy targeting solid tumors, AB201.Accordingly, GC Cell plans to conduct multicountry clinical trials of AB-
Seoul National University Bundang Hospital (SNUBH) announced that its researchers have secured 1.6 billion won ($1.18 million) in research funding for conducting clinical research using artificial intelligence (AI) to select the best embryos for implantation during in vitro fertilization (IVF).Profe
Despite Korea reducing Covid-19 emergency response levels, immunology experts elaborated that the only way to keep the virus under control was through seasonal updated vaccination to adapt to the mutating virus. In response, Moderna Korea held a press conference on Thursday to share data on the clin
GC Biopharma said on Thursday that its drug candidate to treat thrombotic thrombocytopenic purpura (GC1126A) has received orphan drug designation from the U.S. FDA on Sept. 27.Accordingly, the orphan drug designation will provide tax breaks on research and development expenses, exemption from permit